TRADE NEWS: Agilent Technologies Microarray Scanner Approved for In Vitro Diagnostics in China
27 Enero 2015 - 10:00AM
Business Wire
Regulators Approve SureScan Dx as Medical
Device
Agilent Technologies Inc. (NYSE: A) today announced that
the China Food and Drug Administration has approved the company’s
SureScan Dx microarray scanner as a medical device for in vitro
diagnostic use.
“Bringing microarray scanning technology to clinical-quality
standards is an important milestone in moving the advancement of
genome-wide chromosome analysis to the clinic,” said Dr. Richard
Choy, associate professor at the Chinese University of Hong Kong.
“Agilent’s SureScan Dx scanner offers high resolution and
sensitivity as well as dynamic autofocus to correct for differences
in slide thickness. This means high-quality data for analysis.”
The product is CE marked for in vitro diagnostic use in Europe.
It is approved for in vitro diagnostic use in South Korea and
Singapore.
The SureScan Dx microarray scanner comes with an autoloader and
Agilent Microarray Scan Control software. The system measures
fluorescence signals from labeled DNA and RNA targets hybridized to
microarrays, for example, to compare two DNA samples for
differences.
“Agilent is committed to offering quality, precision measurement
equipment to clinical laboratories worldwide,” said Peter
Serpentino, Agilent vice president and general manager for
Genomics. “We are pleased to introduce the SureScan Dx scanner in
China for use in clinical laboratories.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in
life sciences, diagnostics, and applied chemical markets, is the
premier laboratory partner for a better world. Agilent works with
customers in more than 100 countries, providing instruments,
software, services, and consumables for the entire laboratory
workflow. Agilent generated revenues of $4.0 billion in fiscal
2014. The company employs about 12,000 people worldwide.
Information about Agilent is available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and
executive news is available at www.agilent.com/go/news.
for Agilent Technologies Inc.Jennifer Mann,
+1-303-357-2391jmann@webershandwick.com
American Oil & Gas Common Stock (NYSE:AEZ)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
American Oil & Gas Common Stock (NYSE:AEZ)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024